Prevention of Venous Thromboembolism in 2020 and Beyond
- PMID: 32752154
- PMCID: PMC7465935
- DOI: 10.3390/jcm9082467
Prevention of Venous Thromboembolism in 2020 and Beyond
Abstract
Venous thromboembolism (VTE) is the third most common cause of vascular mortality worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In this review, we discuss how an understanding of VTE epidemiology and the results of thromboprophylaxis trials have shaped the current approach to VTE prevention. We will discuss modern thromboprophylaxis as it pertains to genetic risk factors, exogenous hormonal therapies, pregnancy, surgery, medical hospitalization, cancer, and what is known thus far about VTE in COVID-19 infection.
Keywords: COVID; DVT; PE; VTE; cancer; epidemiology; prevention; prophylaxis.
Conflict of interest statement
M.N., J.G., V.B., N.C. have no conflicts of interest relevant to this manuscript.
Figures
References
-
- Anderson F.A., Wheeler H.B., Goldberg R.J., Hosmer D.W., Patwardhan N.A., Jovanovic B., Forcier A., Dalen J.E. A Population-Based Perspective of the Hospital Incidence and Case-Fatality Rates of Deep Vein Thrombosis and Pulmonary Embolism: The Worcester DVT Study. Arch. Intern. Med. 1991;151:933–938. doi: 10.1001/archinte.1991.00400050081016. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical